Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Practice Operations · For practice managers

OSHA Biohazard Safety for In-Office Biologics

Published September 21, 2026

Primary OSHA Standard
29 CFR 1910.1030

Governs bloodborne pathogen safety and exposure control during blood and tissue processing

ECP Review Cadence
Annual Mandatory

Required frequency for reviewing and updating a practice's written exposure control plan

Medical Record Retention
Employment + 30 Years

Required retention period for employee exposure records and vaccination documentation

Meeting OSHA safety and biohazard compliance standards for in office biologic preparation requires implementing 29 CFR 1910.1030 engineering controls—such as sealed centrifuge caps and splash shields—alongside a site-specific Exposure Control Plan and compliant biohazard waste containment. For clinical facilities processing autologous blood components or handling donor tissues, enforcing strict containment procedures eliminates aerosol exposure risks and maintains audit readiness. This operational overview details practical compliance workflows, facility requirements, and essential medical supplies to keep your biologics preparation suite compliant.

Regulatory Framework Governing In-Office Biologic Processing

When medical practices transition from off-the-shelf pharmaceuticals to point-of-care biologic processing, the regulatory footprint expands significantly. Occupational Safety and Health Administration (OSHA) regulations exist to protect healthcare personnel from exposure to infectious materials during collection, centrifuging, isolation, and re-injection.

While FDA regulations (such as 21 CFR 1271) dictate product safety, donor eligibility, and minimal manipulation criteria, OSHA focuses entirely on employee health and environment safety. The primary regulation governing point-of-care biologic handling is OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030). This standard applies to any setting where staff may encounter human blood, body fluids, or human cell and tissue products.

Additionally, OSHA’s General Duty Clause (Section 5(a)(1) of the Occupational Safety and Health Act) requires employers to provide a workplace free from recognized hazards that cause or are likely to cause death or serious physical harm. For practice managers, establishing compliance requires addressing physical space layout, employee training, equipment maintenance, and administrative documentation.

Core Engineering and Work Practice Controls

OSHA mandates a hierarchy of controls to eliminate or minimize employee exposure to biohazards. Engineering controls serve as the primary defense mechanism, physically isolating staff from potential pathogens.

Essential Engineering Controls

  • Aerosol-Containment Centrifuges: Centrifuges used for spinning blood or tissue must feature sealed buckets or gasket-sealed microplate carriers. In the event of tube failure during high-speed rotation, sealed caps prevent biohazardous aerosols from disseminating into room air.
  • Sharps Safety Devices: Blood collection and processing require engineered sharps protection (e.g., self-sheathing needles, safety scalpels, and needleless transfer spikes).
  • Dedicated Processing Areas: Preparation should occur in a restricted-access clean room or designated clean counter space equipped with non-porous, easily sanitized surfaces.

Standard Work Practice Controls

Work practice controls dictate how clinical tasks are executed to reduce exposure probability. Key operational requirements include:

  • Prohibiting eating, drinking, applying cosmetics, or handling contact lenses in biologic prep areas.
  • Standardizing hand hygiene before putting on and after removing personal protective equipment (PPE).
  • Mandating that all specimen containers (tubes, syringes, transfer bags) are labeled with appropriate universal biohazard warnings during processing.

Clinical Safety vs. Operational Risk Management

Maintaining a compliant practice requires aligning clinical objectives with operational oversights. Both clinical providers and practice administrators view compliance through distinct, complementary lenses.

Clinical Perspective: Sample Integrity and Provider Safety

From the clinician’s viewpoint, compliance directly intersects with aseptic technique and patient outcomes. Preventing cross-contamination of point-of-care biologics relies on closed-system fluid transfer and sterile barrier maintenance. Clinicians focus on:

  • Maintaining aseptic technique throughout venipuncture, centrifuging, and draw-up.
  • Utilizing sterile, single-use draw kits to avoid aerosolization during liquid transfer.
  • Protecting themselves against accidental needle sticks during joint injection or dermal application procedures.

Operational Perspective: Procurement, Audit Readiness, and Liability

For practice managers, biohazard compliance represents financial risk management, employee safety documentation, and vendor vetting. Administrators at pain management doctors and specialty practices must manage:

  • Procurement of certified medical-grade supplies, high-barrier gloves, eye protection, and puncture-resistant sharps containers.
  • Maintaining up-to-date Safety Data Sheets (SDS) for all chemical reagents, disinfectants, and processing agents.
  • Documenting initial and annual employee biohazard training sessions, complete with sign-in rosters and training materials.
  • Ensuring third-party medical waste haulers provide verified manifests for regulated medical waste (RMW) destruction.

Mandatory OSHA Biohazard Compliance Checklist

Practice managers should evaluate their current point-of-care preparation workflows against this compliance checklist:

  • Written Exposure Control Plan (ECP): Is a customized ECP accessible to all staff, and has it been updated within the past 12 months?
  • Hepatitis B Vaccination Offerings: Are documented proof of Hepatitis B vaccination or signed declination forms on file for all clinical staff?
  • Personal Protective Equipment (PPE): Does the practice supply gloves, fluid-resistant lab coats/gowns, and face shields or goggles at no cost to employees?
  • Centrifuge Protocol: Are biological specimens spun in sealed rotor buckets or sealed caps to contain aerosol hazards?
  • Sharps Disposal Containers: Are rigid, leak-proof, puncture-resistant sharps containers located immediately adjacent to drawing and preparation stations?
  • Decontamination Protocols: Is an EPA-registered intermediate-level disinfectant used for cleaning work surfaces after every biologic preparation cycle?
  • Post-Exposure Protocol: Is there a clear, documented procedure for immediate medical evaluation, prophylaxis, and incident reporting in the event of a needle stick or splash exposure?

Equipment Procurement and Facility Layout Standards

Facility design directly impacts a practice's ability to maintain OSHA compliance. Biologic preparation should never occur in generic office spaces or high-traffic staff hallways. Establishing a dedicated clean preparation zone—supported by reliable technologies—ensures both safety and workflow efficiency.

Practices utilizing open-system manipulations (such as manual tissue pipetting or custom compounding) must evaluate whether a Class II Biological Safety Cabinet (BSC) or laminar flow hood is necessary to protect both the sample from room air and the operator from aerosols. For standard closed-system PRP kits, dedicated counter space equipped with smooth, seamless countertops (e.g., solid surface or stainless steel) allows for complete chemical decontamination.

Stocking adequate clinical inventory—from biohazard transport bags to proper protective apparel—is critical. Partnering with suppliers who provide certified, compliant medical supplies helps management maintain seamless supply chain oversight while fulfilling regulatory obligations.

What This Means for Your Practice

To ensure your facility meets all OSHA biohazard standards without slowing down clinical operations, take the following immediate steps:

  1. Audit Your Preparation Space: Inspect the physical layout of your biologic processing area. Ensure sharps containers are positioned within arm's reach and centrifuges feature sealed caps.
  2. Review Your Written Exposure Control Plan: Verify that your written ECP specifically addresses in-office biologic collection, processing, and injection steps, rather than generic office blood draws.
  3. Verify PPE Availability & Utilization: Confirm that clinical staff consistently wear full PPE (gloves, protective eyewear, lab coats) during all preparation phases.
  4. Audit Employee Files: Ensure all clinical team members have up-to-date bloodborne pathogen training certificates and recorded Hepatitis B status on file.

For guidance on selecting compliant processing equipment, medical-grade supplies, and establishing efficient clinical workflows for your facility, contact our team at Dallas Regenerative Solutions.

Frequently asked questions

What OSHA standards apply to in-office PRP centrifuging and biologic preparation?
In-office PRP centrifuging and biologic preparation are governed primarily by OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) and the General Duty Clause. Practices must maintain a written Exposure Control Plan, provide appropriate personal protective equipment, use engineered safety devices, and enforce proper waste disposal procedures.
Does in-office biologic preparation require a biological safety cabinet (BSC)?
Closed-system biologic preparations, such as commercial PRP kits using sealed tubes and centrifuges, typically do not require a biological safety cabinet. However, if your practice performs open-system processing or handles unsealed tissue components where exposure to aerosols or ambient contamination is possible, a Class II BSC may be necessary.
How long must medical practices retain employee biohazard training and exposure records?
OSHA requires biohazard training records to be maintained for 3 years from the date of the training session. Employee medical records, including Hepatitis B vaccination records and post-exposure evaluation documentation, must be retained for the duration of employment plus 30 years.
What features are required for a centrifuge used in biologic processing?
Centrifuges used for processing bloodborne biologics should feature aerosol-containment caps or sealed rotor buckets. These engineering controls prevent biohazardous aerosols from leaking into the room environment in the event of blood tube breakage during rotation.
Who is responsible for providing personal protective equipment (PPE) for clinical staff?
Under OSHA regulations, the employer is legally required to provide all appropriate personal protective equipment—including gloves, gowns, masks, and eye protection—at no cost to employees who face occupational exposure risks.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →